Johnson & Johnson stock heads into the open after a 0.7% gain
Published on 09/07/2026 at 07:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson stock closed at USD 275.12 on the NYSE on September 4, 2026, gaining 0.7% from the prior session. Market data show that this move came as large institutional holders reported updated positions in the company, underlining continued interest from long-term investors. The same session saw the S&P 500 index post a moderate advance, so the stock roughly tracked the broader market rather than moving against it.
September 4, 2026 in numbers
Johnson & Johnson Inc. (ISIN US4781601046, NYSE: JNJ) finished the September 4, 2026 session at USD 275.12 after opening near USD 273 and trading in a day range roughly between USD 272.40 and USD 276.30. According to a series of institutional holding updates summarized by MarketBeat, several asset managers reported Johnson & Johnson as one of their larger positions, with one filing describing it as a top-four holding and citing an opening level of USD 275.12 for the Friday session. This MarketBeat summary noted that institutional interest remained strong into the start of September.
Across related filings for September 6, 2026, MarketBeat reported that other managers, including Manning & Napier Advisors LLC and Trajan Wealth LLC, also listed Johnson & Johnson as a significant holding, again tying their commentary to the Friday, September 4, 2026 price level of USD 275.12. One MarketBeat note highlighted Johnson & Johnson stock as a core position even as some shares were reallocated. With the shares ticking higher and closing well within their 52-week range, the stock maintained a relatively stable profile compared with more volatile names, while the S&P 500’s modest climb provided a supportive backdrop rather than a distinct catalyst.
Outlook today
Today, September 7, 2026, Johnson & Johnson faces no major company-specific events such as an earnings release or annual meeting that have been flagged in recent filings or calendars, so attention stays on broader market drivers and health-care sector sentiment. In the absence of a fresh company announcement this morning, trading ahead of the opening bell is likely to be influenced by ongoing institutional positioning and any shifts in market expectations around interest rates and defensive sectors. Health-care peers reporting results or guidance updates over the coming days, as well as macro data releases affecting the S&P 500, may provide context for Johnson & Johnson stock, but no single scheduled item stands out as a decisive catalyst for today’s session.
